Rubin et al. Am J Gastroenterol 2019
Lichtenstein et al. Am J Gastroenterol 2018
Ko et al. Gastroenterology 2019
Feuerstein et al. Gastroenterology 2020
Leontiadis et al. Gastroenterology 2015
Steinhart et al. Inflammatory Bowel Diseases 2019
Torres et al. JCC 2020
CONCLUSIONS: The claims-based algorithm developed for use in Japan is likely to identify UC cases with high PPV for clinical studies using administrative claims databases. Full Text Link:...
Read MoreCONCLUSION: Deep learning methods are feasible and have the potential for stronger predictive performance compared to conventional model building methods when applied to predicting remission after anti-TNF therapy in CD. Full...
Read MoreNo abstract Full Text Link: https://libkey.io/34534537?utm_source=ibdwatch
Read MoreCONCLUSIONS: Patients with IBD may be at increased risk of some vaccine-preventable diseases. Therefore, maintaining appropriate vaccination status in these patients is critical to optimize patient outcomes. In general, IBD is...
Read MoreCONCLUSIONS: Many guidelines do not provide recommendations on key aspects of CRC prevention in IBD. Over 90% of recommendations are based on low- to moderate-quality evidence; therefore, further studies on CRC prevention in IBD...
Read MoreNo abstract Full Text Link: https://libkey.io/34051986?utm_source=ibdwatch
Read MoreNo abstract Full Text Link: https://libkey.io/34051983?utm_source=ibdwatch
Read MoreInflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) and Crohn’s disease (CD). Since 1950, the...
Read MoreNo abstract Full Text Link: https://libkey.io/33674339
Read MoreRelated ArticlesCANADIAN ASSOCIATION OF GASTROENTEROLOGY CLINICAL PRACTICE GUIDELINE FOR IMMUNIZATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD). PART 1: LIVE VACCINES. Gastroenterology. 2021 Feb 19;: Authors: Benchimol...
Read More